Details for New Drug Application (NDA): 074930
✉ Email this page to a colleague
The generic ingredient in ACYCLOVIR SODIUM is acyclovir sodium. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.
Summary for 074930
| Tradename: | ACYCLOVIR SODIUM |
| Applicant: | Fresenius Kabi Usa |
| Ingredient: | acyclovir sodium |
| Patents: | 0 |
Pharmacology for NDA: 074930
| Mechanism of Action | DNA Polymerase Inhibitors |
Suppliers and Packaging for NDA: 074930
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ACYCLOVIR SODIUM | acyclovir sodium | INJECTABLE;INJECTION | 074930 | ANDA | Fresenius Kabi USA, LLC | 63323-325 | 63323-325-14 | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-325-14) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-325-41) |
| ACYCLOVIR SODIUM | acyclovir sodium | INJECTABLE;INJECTION | 074930 | ANDA | Fresenius Kabi USA, LLC | 63323-325 | 63323-325-24 | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-325-24) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-325-43) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 50MG BASE/ML | ||||
| Approval Date: | May 13, 1998 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
